{"entity":{"id":"da-tech-tau-therapeutics","kind":"technology","name":"Tau-directed therapeutics","aka":[],"tldr":"Tau-directed treatments are in trials. None is an approved dementia medicine on this atlas.","summary":"Because tau tracks clinical progression, it is a major pipeline theme. Benefit and safety remain trial questions.","status":"emerging","asOf":"2026-09-21","links":[{"label":"ClinicalTrials.gov","url":"https://clinicaltrials.gov"}],"tags":["dementia-atlas"],"related":[],"cancers":[],"sections":["da-front-anti-tau"],"technologies":[],"targets":["da-target-tau"],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"principle":"Antisense, antibody, or small-molecule approaches aimed at tau protein.","strengths":[],"limitations":[]},"route":"/technologies/da-tech-tau-therapeutics/","neighbours":{"section":[{"id":"da-front-anti-tau","kind":"section","name":"Anti-tau research","route":"/fronts/da-front-anti-tau/"}],"target":[{"id":"da-target-tau","kind":"target","name":"Tau","route":"/targets/da-target-tau/"}],"cancer":[{"id":"alzheimers-disease","kind":"cancer","name":"Alzheimer’s disease","route":"/diagnoses/alzheimers-disease/"}]}}